Daniele Roberto Giacobbe
Overview
Explore the profile of Daniele Roberto Giacobbe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
225
Citations
4057
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cappello A, Murgia Y, Giacobbe D, Mora S, Gazzarata R, Rosso N, et al.
Front Antibiot
. 2025 Jan;
3():1380380.
PMID: 39816258
Antimicrobial resistance in bacteria has been associated with significant morbidity and mortality in hospitalized patients. In the era of big data and of the consequent frequent need for large study...
12.
Vena A, Tiseo G, Falcone M, Bartalucci C, Marelli C, Cesaretti M, et al.
Clin Infect Dis
. 2025 Jan;
PMID: 39810592
Background: This study assesses the impact of fluconazole resistance on 30-day all-cause mortality and 1-year recurrence in patients with Candida parapsilosis bloodstream infections (BSI). Methods: A multicenter retrospective study was...
13.
Vena A, Castaldo N, Giacobbe D, Fantin A, Bassetti M
Curr Opin Infect Dis
. 2025 Jan;
38(2):122-127.
PMID: 39786987
Purpose Of Review: To evaluate the current evidence on the use of omadacycline for the treatment of skin and soft tissue infections (SSTIs). Recent Findings: This narrative review examines the...
14.
Hatzl S, Posch F, Scholz L, Geiger C, Kriegl L, Kreuzer P, et al.
Clin Microbiol Infect
. 2024 Dec;
PMID: 39732393
Background: Pneumocystis jirovecii pneumonia (PCP) is a serious opportunistic infection in people living with HIV (PWH) who have low CD4 counts. Despite its side effects, trimethoprim-sulfamethoxazole (TMP-SMX) is currently considered...
15.
Weaver D, Gago S, Bassetti M, Giacobbe D, Prattes J, Hoenigl M, et al.
Microbiol Spectr
. 2024 Dec;
13(2):e0411023.
PMID: 39699254
Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a life-threatening complication in patients with severe COVID-19. Previously, acute respiratory distress syndrome in patients with COVID-19 has been associated with lung...
16.
Bassetti M, Stewart A, Bartalucci C, Vena A, Giacobbe D, Roberts J
Expert Opin Drug Metab Toxicol
. 2024 Nov;
21(2):125-132.
PMID: 39552377
Introduction: Rezafungin, formerly SP3025 and CD101, is a next-generation echinocandin, chemically related to anidulafungin, with differentiated pharmacokinetic characteristics, including a prolonged half-life allowing extended-interval dosing. Areas Covered: Herein, we discuss...
17.
Bassetti M, Larosa B, Vena A, Giacobbe D
Expert Rev Anti Infect Ther
. 2024 Sep;
22(11):965-976.
PMID: 39292619
Introduction: Several novel agents are in advanced stages of clinical development, potentially expanding our treatment options against third- and fourth-generation cephalosporin-resistant and carbapenem-resistant Gram-negative bacteria (GNB), including those pathogens for...
18.
Bassetti M, Giacobbe D, Castaldo N, Vena A
Curr Opin Infect Dis
. 2024 Sep;
37(6):547-553.
PMID: 39259710
Purpose Of Review: Infections caused by multidrug-resistant Acinetobacter baumannii present a significant global health challenge. Available treatment options are limited and frequently constrained by unfavourable safety and pharmacokinetic profiles. Sulbactam-durlobactam...
19.
Vena A, Schenone M, Corcione S, Giannella M, Pascale R, Giacobbe D, et al.
J Antimicrob Chemother
. 2024 Sep;
79(11):2846-2853.
PMID: 39224938
Objectives: To determine the association of adequate empirical combination therapy (AECT) with 30-day all-cause mortality in patients with septic shock due to Pseudomonas aeruginosa bloodstream infections (BSI). Methods: This multicentre,...
20.
COVID-19 throughout pandemic waves and virus variants: a real-life experience in an Italian hospital
Dettori S, Brucci G, Portunato F, Ponzano M, Magnasco L, Mirabella M, et al.
J Chemother
. 2024 Aug;
:1-9.
PMID: 39161053
New therapies and vaccines changed the management of COVID-19. The aim of this retrospective study was to describe characteristics, in-hospital mortality and its predictors in patients with moderate/severe COVID-19, considering...